Compare FMC Corp (FMC) vs TJX Companies Inc (TJX) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

TJX Companies (TJX) trades at $154.81, up 2.97% today, with strong earnings beats in recent quarters. The stock shows a bullish fundamental profile with 9.4% net income margin and 61.25% ROE, though technical indicators signal near-term bearish pressure. Revenue growth accelerated to $56.36B in 2025, with analyst consensus strongly favoring Buy ratings (88.46%). Recent news highlights TJX as a defensive retail play during economic uncertainty, with expansion in international markets like Europe and Australia.

Outlook remains positive given consistent earnings outperformance and robust cash flow, but valuation multiples (P/E 29.37) suggest premium pricing. Key risks include consumer spending volatility and competitive pressures. Wall Street's average price target of $181.80 implies ~17% upside, supported by institutional confidence and dividend stability.